The current valuation score of NovaBay Pharmaceuticals Inc is 4.94, ranking 153 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -0.51, which is -702.50% below the recent high of 3.09 and -4348.83% above the recent low of -22.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.